JIPMER to end application deadline for Submission Of Proposal To Institutional Ethics Committee Observational studies For January 2024

Published On 2024-01-01 03:30 GMT   |   Update On 2024-01-01 03:30 GMT
Advertisement

Puducherry: Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER) is going to close the window for online applications for submission of proposals to the Institutional Ethics Committee (IEC) Observational studies for January 2024.

The last date for submission of proposals so as to reach the office of the undersigned for consideration of approval by the Institutional Ethics Committee for the month of January 2024 is on or before 02-01-2024. Proposals submitted before the last date will be taken up for discussion in the IEC Observational Committee meeting scheduled to be held on 11-01-2024.

Faculty, PhD scholars, PG and UG Students can submit research proposals approved by JSAC/PGRMC/SCTRC/GJ-STRAUS for approval by the Institutional Ethics Committee – Observational studies in the prescribed proforma available on the website. The link for filling out the online version of the JIEC application form and relevant annexures is mentioned in the notice below. The applicants need to upload the soft copy at the link mentioned in the notice below.

One original hard copy of the following documents is required to be submitted to the Member-Secretary, Institute Ethics Committee (IEC) at the Institute Ethics Committee office, Room no. 106, First floor, Administrative block, JIPMER –

1. Covering letter

2. Download of the online IEC application

3. Signed Declaration form

4. Consent forms / Waiver of consent forms

5. Research proposal JSAC (ver. July 2020) / UGRMC/PGRMC

6. JSAC/ UGRMC/PGRMC certificate

7. Data collection proformas

8. Curriculum vitae of PI & Co-Investigator (s) / guide & co-guide

The applicants note that they need to enter the complete title of the project, the Department of Work, and the Investigator’s name on the first page of the application.

Instructions for filling out consent forms –

1. The Informed Consent Document should comprise the Patient Information Sheet and the consent forms in English and Tamil.

2. The investigator must provide information to the subjects in simple language (avoid medical jargon). Please avoid copying & pasting from other study protocol

3. It should address the subjects, in a dialogue format

4. A separate consent form for the patient/test group and control (drug/procedure or placebo) should be provided as applicable

5. In case of telephonic contact, please add a telephonic script in addition to the PIS format

Studies involving children –

If participants are children, the participant information sheet should address the parents/LAR of the children and should be worded accordingly –

 Children <7 years - include parent / LAR consent form

Children 7-12 years - in addition to the parent / LAR consent form, record verbal assent in the LAR form

Children 12 - 18 years of age - include written assent form

Assent form should provide information about the study in a simple language comprehensible to a child from 12-18 years.

Assent form should provide information about the study in a simple language comprehensible to a child from 12-18 years.

The language used should be simpler for children in the age group 7-12 years compared to children in the age group 12-18 years.

To view the notice, click on the link below –

https://medicaldialogues.in/pdf_upload/iec-os-call-for-proposal-january-2024final-228318.pdf

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News